North America holds a dominant share of the ELISA Analyzers Market, driven by its highly developed healthcare infrastructure, widespread adoption of advanced diagnostic technologies, and strong presence of leading life sciences and diagnostic companies. The region benefits from increasing demand for infectious disease testing, biomarker analysis, and clinical research applications, all of which...